Live feed
Filing
SC 13G/A
SC 13G/A0001104659-24-021351·LIGAND PHARMACEUTICALS INC
Schedule 13G ownership disclosure
Ligand Pharmaceuticals Inc
Security class unavailable · CUSIP: 53220K504
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,876,514
- Percent of class
- 10.7600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-021351
- Form type
- SC 13G/A
- Filer
- LIGAND PHARMACEUTICALS INC
- CIK
- CIK 886163
- Filed
- Feb 13, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership